The War on Cancer: New Drugs for Advanced Kidney Cancer -- Do They Work?

Tagged:  

PFIZER Inc.
DRUG development
KIDNEYS -- Cancer
CANCER -- Treatment
Geographic Terms:UNITED States

Abstract:The article discusses the development of the new drug Sutent from Pfizer Inc. which is as a treatment for advanced kidney cancer in the U.S. The author talks about the approval by the European Union following the drug's approval in the U.S. Moreover, he focuses on the efficacy of the drug as well as its manageable adverse-event profile.

Share this with your friends
AttachmentSize
The War on Cancer-- New Drugs for Advanced Kidney Cancer -- Do They Work.pdf1.51 MB